Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Drug Labeling Format Encourages Physician-Patient Interaction

Executive Summary

FDA's final labeling rule creates several new sections designed to facilitate physicians' drug prescribing practices

You may also be interested in...



Patient Counseling Section Of Labeling Should Be Limited, FDA Advises

Only the most important, not necessarily the most common, side effects should be included in the section denoting what a health care provider should tell a patient, FDA’s draft guidance says; section was mandated under 2006 physician labeling rule.

Allergan Bats Its Eyes At Consumers With Latisse Marketing Campaign

Allergan is charting new territory in marketing its eyelash growth stimulant Latisse, a product with a purely aesthetic indication that will be uniquely consumer-driven

Allergan Bats Its Eyes At Consumers With Latisse Marketing Campaign

Allergan is charting new territory in marketing its eyelash growth stimulant Latisse, a product with a purely aesthetic indication that will be uniquely consumer-driven

Related Content

UsernamePublicRestriction

Register

PS046864

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel